Skip to main content

The TRAVERSE Trial

Meaning

The TRAVERSE Trial, formally the Cardiovascular Safety of Testosterone Replacement Therapy in Men with Hypogonadism Trial, is a large-scale, randomized, placebo-controlled clinical trial designed to definitively assess the long-term cardiovascular safety of testosterone replacement therapy (TRT) in men with hypogonadism. This landmark study was mandated by regulatory bodies to provide robust, evidence-based data regarding the risks and benefits of TRT on major adverse cardiovascular events (MACE). The results of this trial are highly influential in shaping clinical practice guidelines for androgen optimization.